A TWICE-YEARLY INJECTION OFFERS 100% PROTECTION AGAINST HIV, STUDY SUGGESTS

Summary from the TLDR newsletter

Results from a recent study on Sunlenca, an HIV preventive injection, found it provided 100% protection against the disease. There were no infections among the 5,000 female study participants who received the shots. The shots still need to be tested in men before the drugmaker Gilead will seek permission to use it as a protection against infection. Sunlenca is already approved as a treatment for HIV in the US, Canada, Europe, and elsewhere. Gilead will pursue a voluntary licensing program that will allow a select number of generic producers to make the drug.